Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs WeightCare

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and WeightCare head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 136 · Grade C

WeightCare

Visit WeightCare Full brief →

FDA warning letter, February 2026 — issued to Weightless Medical LLC dba WeightCare. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make WeightCare a bad call — it's best for readers comparing monthly flexibility with prepaid packages who will check the renewal charge and dose coverage. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
77
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
87
Track Record
88
64
CoreAge RxBrief Score 94 · 72WeightCare

Price, coverage & the tracker

CoreAge RxWeightCare
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$399/mo monthly plan

Compounded semaglutide; three-month starter $747 upfront. Confirm later-dose pricing and state eligibility.

Full price details

$399/month compounded semaglutide plan; $747 upfront for the listed 3-month starter option; confirm continuation dose and price

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$499/mo monthly plan

Compounded tirzepatide; three-month starter $897 upfront, listed three-month renewal $997 at 7.5 mg. Higher doses differ.

Full price details

$499/month compounded tirzepatide plan; $897 upfront for the listed 3-month starter; renewal and high-dose packages differ

CoverageUS only; restrictions by state, confirmed at intakeStandard GLP-1 FAQ excludes AK, HI, LA and MS; Alabama eligibility conflicts on the semaglutide page. Other programs have different exclusions
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

WeightCare: Monthly plans are $399 for semaglutide and $499 for tirzepatide. The $897 tirzepatide starter package differs from its listed $997 three-month renewal.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.